New recommendations for IBD patient during the COVID-19 Pandemic
Summarized from the International Organization for the Study of Inflammatory Bowel Disease
- IBD patients do not seem to be at any increased risk of contracting the coronavirus that causes COVID-19 pandemic, compared to people without IBD.
- In general, it is recommended in patients who are asymptomatic and at lower risk for COVID-19, to continue their current medications for IBD. The exception to this is of prednisone (see below).
- Taking prednisone at doses of greater than 20mg daily may be linked to a higher risk of contracting and having a more serious infection with COVID-19. Speak to your doctor right away if you can taper off these medications (do not discontinue yourself as this can be dangerous to do so)
- If you do develop COVID-19 infection, certain IBD medications including certain biologic drugs (injections/infusions) may need to be held for at least 14 days or until you recover and/or test negative for the corona virus. Speak to your gastroenterologist immediately if you do test positive or develop symptoms of a cough, fever, sore throat or shortness of breath.
What is Ulcerative Colitis and Crohn’s Disease?
March 23, 2021 at 4 p.m.
Join Caroline Hwang, M.D. gastroenterologist and Director of Hoag’s Margolis Family Inflammatory Bowel Disease Program as she discussed the signs and diagnosis of ulcerative colitis and Crohn’s disease.
COVID-19 Notice: For the safety of our community, we are only offering live streaming and virtual classes at this time.
Contact Us at 888-522-0014
*Please note: This is an information line only. Should you need to speak directly to your physician’s office regarding your healthcare issue or an appointment, please call your physician’s office directly.